Ashley Gallagher, Associate Editor

The FDA has approved a second drug, zanubritinib, for the treatment of adult patients with Waldenström’s macroglobulinemia.

Published results indicate that marriage, urban living put people less at risk for cardiovascular problems.

FDA’s green light for biopharmaceutical company’s drug candidate builds upon previous approval to treat pancreatic cancer.

Brigham and Women’s Hospital conducted an analysis to measure the response of T cells from MMR and Tdap vaccines that could help to decrease COVID-19 severity.

St. Jude Children’s Research Hospital reminds parents about the importance of getting the HPV vaccination during National Immunization Awareness Month.

New paper shows that pregnant women often have low iron levels, while 1 in 4 have a severe deficiency.

Pharmaceutical companies continue trial for GBP510 in conjunction with GSK’s pandemic adjuvant.